Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
| Autor: | Mahilet Berhanu Habte, Aderajew Nigusse Tekelehaimanot, Walelign Atomsa Tucho |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
child
medicine.medical_specialty Interview business.industry medicine.medical_treatment antiretroviral therapy Logistic regression Pediatrics Antiretroviral therapy RJ1-570 World health Checklist Support group 03 medical and health sciences 0302 clinical medicine 030225 pediatrics Family medicine Cohort medicine 030212 general & internal medicine Hiv status disclosure business Pediatric Health Medicine and Therapeutics Original Research |
| Zdroj: | Pediatric Health, Medicine and Therapeutics, Vol Volume 12, Pp 299-306 (2021) Pediatric Health, Medicine and Therapeutics |
| ISSN: | 1179-9927 |
| DOI: | 10.2147/phmt.s314259 |
| Popis: | Walelign Atomsa Tucho,1 Aderajew Nigusse Tekelehaimanot,2 Mahilet Berhanu Habte2 1Department of Disease Prevention and Control, Bench Sheko Zone Health Office, Mizan-Aman, Southwest Ethiopia; 2Department of Population and Family Health, Faculty of Public Health, Jimma University, Jimma, EthiopiaCorrespondence: Mahilet Berhanu Habte Tel +251-912246413Email mahitesfa.mt@gmail.comBackground: The World Health Organization recommends that children should be informed of their HIV status at age 6â 12 years. However, disclosure of HIV status among children is very low in resource-limited areas, particularly in Ethiopia. So, the aim of this study was to determine the prevalence of disclosure and associated factors among a cohort of HIV-infected children in southwest Ethiopia.Methods: A facility-based cross-sectional study design was employed among caregivers of HIV-positive children aged 6â 15 in Bench sheko and West Omo zone Southwest Ethiopia, from March 1 to April 20, 2020. Study participants were included using a consecutive sampling technique. Data were collected using a pretested interviewer administered questionnaire and checklist. A multivariable logistic regressions model was used to identify independent predictors of disclosure. The significance of association was declared by AOR at 95% confidence and a p-value < 0.05.Results: A total of 327 participants were involved in the study yielding a 95% response rate. The prevalence of HIV-positive status disclosure was 45.6% (95% CI=41.01â 51.02). Caregiver secondary education and above (AOR=3.16, 95% CI=1.07â 9.34), caregiver discussed about disclosure with health professionals (AOR= 9.56, 95% CI=4.88â 18.74), child age 10â 15 year old (AOR=3.64, 95% CI=1.64â 8.08), duration on ART > 5 years (AOR=5.08, 95% CI=1.57â 16.37), treatment follow-up at hospital (AOR=2.23, 95% CI=1.27â 5.01) and having treatment support for Children (AOR=3.84, 95% CI=1.88â 7.85) were independent predictors of HIV-positive status disclosure.Conclusion: Disclosure of HIV status to children is low. Caregivers educational status, caregivers discussion with health professional, older child, duration on ART of more than 5 year, getting treatment service from hospital, and having a treatment support group are factors that enable disclosure. Therefore, concerted efforts based on the findings of this study will be required to improve the disclosure status among HIV-positive children.Keywords: disclosure, antiretroviral therapy, child |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|